Relationship between lipid abnormalities and insulin resistance in Japanese school children

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 12, 2006, Pages 2781-2786

  Asato, Yoshihide ^a   Katsuren, Keisuke ^a   Ohshiro, Tadashi ^a   Kikawa, Kazuhide ^a   Shimabukuro, Tadao ^a   Ohta, Takao ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Hyperlipidemia; Insulin resistance; Obesity; School children; Type 2 diabetes

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; BODY WEIGHT; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; JAPAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SCHOOL CHILD; STANDARD; TRIACYLGLYCEROL BLOOD LEVEL;

BODY WEIGHT; CHILD; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; OBESITY; PHENOTYPE; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 33751168044     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000245804.56871.31     Document Type: Article

References (32)

1. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med. 1984;76:4-12.
2. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
3. Pathobiological Determination of Atherosclerosis in Youth Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA. 1990;264:3018-3024.
4. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656.
5. Ohta T, Kiwaki K, Endo F, Umehashi H, Matsuda I. Dyslipidemia in young Japanese children: its relation to familial hypercholesterolemia and familial combined hyperlipidemia. Pediatr Int. 2002;44:602-607.
6. Okada T, Murata M, Yamauchi K, Harada K. New criteria of normal serum lipid levels in Japanese children: The nationwide study. Pediatr Int. 2002;44:596-601.
7. Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat. Clin Pediatr. 1998;37:111-115.
8. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-810.
9. Shimabukuro T, Subagawa M, Ohta T. Low-density lipoprotein particle size and its reguratory factors in school children. J Clin Endocrinol Metab. 2004;89:2923-2927.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complication. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med. 1998;15:539-553.
11. The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Education, and Treatment of High Blood Cholesterol In Adult (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
12. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89:2601-2607.
13. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89:108-113.
14. Rodriguez-Moran M, Salazar-Vazquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care. 2004;27:2516-2517.
15. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374.
16. Ikeda T, Shibuya U, Sugiuchi H, Araki S, Uji Y, Okabe H. Automated immunoturbidimetric analysis of six serum apolipoproteins: correlation with radial immunodiffusion assays. J Clin Lab Anal. 1991;5:90-95.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
19. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents. Diabetes Care. 2004;27:314-319.
20. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500-e503.
21. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995;95:158-166.
22. Taskinen MR. Insulin resistance and lipoprotein metabolism. Curr Opin Lipodol. 1995;6:153-160.
23. Yamashita S, Matsuzawa Y, Okazaki M, Kako H, Yasugi T, Akioka H, Hirano K, Tarui S. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis. 1988;70:7-12.
24. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol. 1998;18:1723-1729.
25. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-481.
26. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell. 1996;87:377-389.
27. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science. 1996;274:1185-1188.
28. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med. 2003;228:1111-1117.
29. Karhapaa P, Uusitupa M, Voutilainen E, Laakso M. Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia. Clin Pharmacol Ther. 1992;52:620-626.
30. Riccardi G, Genovese S, Saldalamacchia G, Patti L, Marotta G, Postiglione A, Rivellese A, Capaldo B, Mancini M. Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes. Atherosclerosis. 1989;75:175-181.
31. Winkler K, Konrad T, Fullert S, Friedrich I, Destani R, Baumstark MW, Krebs K, Wieland H, Marz W. Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. Diabetes Care. 2003;26:2588-2594.
32. Veerkamp MJ, Graaf J, Stalenhoef AFH. Role of insulin resistance in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2005;25:1026-1031.